Lawrence Klein
Vermögen: 54 Mio $ am 31.05.2026
Vermögen: 54 Mio $ am 31.05.2026
Lawrence O. Klein ist Mitglied des Vorstands von Dyne Therapeutics, Inc. und Chief Operating & Business Officer bei CRISPR Therapeutics AG. Dr. Klein war zuvor als Associate Partner bei Mckinsey & Co. (Schweiz). Dr. Klein erhielt einen Doktortitel von der Stanford University und einen Bachelor-Abschluss von der University of Wisconsin.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
1,91 % | 15.06.2026 | 925.580 ( 1,91 % ) | 54 Mio $ | 31.05.2026 |
| 09.06.2026 | 70 ( 0 % ) | 1 473 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| JADE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 28.04.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Private Equity Investor | 01.02.2024 |
| JASPER THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 20.06.2023 |
| DYNE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 24.05.2023 |
| CRISPR THERAPEUTICS AG | Geschäftsführer | 01.10.2022 |
Mckinsey & Co. (Switzerland)
Mckinsey & Co. (Switzerland) Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Corporate Officer/Principal | 01.02.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Mckinsey & Co. (Switzerland)
Mckinsey & Co. (Switzerland) Miscellaneous Commercial ServicesCommercial Services Provides business management consulting services | Commercial Services |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen